GLP-1 medications work by suppressing appetite. Caloric intake drops 30–40%. Patients eat less, and the weight comes off. But when caloric intake plummets, so does micronutrient intake. The result: over 90% of long-term GLP-1 patients are deficient in at least one critical micronutrient.

90%+
of GLP-1 patients are deficient in at least one critical micronutrient—most commonly Vitamin D, B12, magnesium, and potassium. Only 20% receive a referral to a registered dietitian.
Source: Heymsfield et al., Lancet Diabetes & Endocrinology, 2024

The Most Common Deficiencies

  • Vitamin D: Critical for bone health, immune function, and mood. Deficiency rates exceed 70% in GLP-1 populations, compounded by reduced dietary fat (which aids Vitamin D absorption).
  • Vitamin B12: Essential for neurological function and energy metabolism. Deficiency manifests as fatigue, cognitive fog, and peripheral neuropathy. Metformin co-prescription (common in diabetic patients) further depletes B12.
  • Magnesium: Required for over 300 enzymatic reactions including muscle function and blood sugar regulation. GLP-1-related GI side effects (nausea, diarrhea) accelerate magnesium loss.
  • Potassium: Critical for cardiac function and blood pressure regulation. Reduced food intake and GI disturbances combine to create significant potassium gaps.

The 20% Problem

Only one in five patients prescribed GLP-1 medications receives a referral to a registered dietitian. The other 80% navigate severe appetite suppression without nutritional guidance—an approach that would be considered malpractice in virtually any other context of involuntary caloric restriction.

Sponsored · Teleios Health

Your GLP-1 Should Come With a Protocol

Labs, protein targets, resistance training, physician oversight. The complete system starting at $99/mo.

Start Your Program →

Bone Density: The Silent Risk

Rapid weight loss from any cause reduces bone mineral density. Combined with Vitamin D and calcium deficiencies, GLP-1 patients face a compounding osteoporosis risk that may not manifest for years. The American College of Sports Medicine recommends bone density screening for any patient with >15% body weight loss—a threshold most GLP-1 patients exceed.

The Evidence-Based Solution

Baseline labs before initiating therapy. Quarterly monitoring thereafter. A targeted supplement protocol (Vitamin D3, B12, magnesium glycinate, fiber, omega-3s). Individualized macro targets from a registered dietitian or physician who understands the unique nutritional challenges of GLP-1 therapy. This is not premium care. This is the minimum standard.

Clinical Advisory

Any patient on GLP-1 therapy should have Vitamin D, B12, ferritin, magnesium, potassium, and a comprehensive metabolic panel drawn before initiation and every 90 days thereafter. Hair loss, fatigue, muscle cramps, and cognitive fog are not "normal side effects"—they are symptoms of treatable deficiencies.